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Abstract 
Clinical  research  is  increasingly  relying  on 
information  gathered  and  managed  in  different 
database  systems  and  institutions.  Distributed  data 
collection and management processes in such settings 
can be extremely complex and lead to a range of issues 
involving the integrity and accuracy of the distributed 
data.  To  address  this  challenge,  we  propose  a 
middleware framework for assessing the data integrity 
and  correctness  in  federated  environments.  The 
framework  has  two  main  elements:  (1)  a  test  model 
describing  the  dependencies  between  and  constraints 
on  data  sources  and  datasets,  and  (2)  a  family  of 
testing  techniques  that  create  and  execute  test  cases 
based on the model.  
1.  Introduction 
A  growing  number  of  studies  gather  and  manage 
information  from  multiple  data  types  and  sources. 
Logistics,  regulations,  and  data-analysis  requirements 
may  not  always  allow  for  centralized  data  gathering 
and management. Data may be collected from patients 
recruited  at  multiple  institutions.  Even  within  an 
institution,  data  may  be  collected  and  processed  by 
different  laboratories  because  of  instrumentation  and 
analysis  requirements.  Federated  systems  have  been 
developed  and  employed  [1,2,3,4]  for  these  types  of 
studies to support distributed data access and analysis 
requirements. An important component that is missing 
in most existing systems is a middleware framework 
for testing the data integrity and correct operation of a 
federated environment.  
Data  sources  in  a  federated  environment  change 
over  time—  data  management  systems  are  modified, 
data models and ontologies are changed, new datasets 
are  gathered,  and  existing  datasets  are  updated. 
Federated  databases  are  often  managed  by  different 
groups;  a  group  may  modify  their  database  without 
informing  other  groups,  causing  inconsistencies  and 
breaking  dependencies  within  the  federated 
environment.  Errors  may  arise  from  both  human 
mistakes  and  faults  in  the  software.  For  example, 
updates  to  data  may  introduce  hard-to-detect  errors. 
Indeed,  such  errors  occurred  in  one  of  our  studies, 
when  a  subset  of  the  clinical  database  we  accessed 
remotely  was  updated  erroneously,  replacing  old 
diagnosis values with new values that did not match the 
known  progression  of  the  disease.  Detecting  and 
tracking  this  and  other  types  of  errors  (Section  2 
describes additional examples of errors) manually in a 
federated  environment  is  impractical,  and  their   
presence  can  seriously  compromise  the  results  of  a 
clinical research project.   
Some  databases  and  ETL  (Extract,  Translate, 
Load)  processes  implement  data  quality  and  error 
checks. In practice, however, most implementations are 
done  as  one-off  solutions  via  low-level  scripts  and 
programs, which can be difficult to extend or modify 
for new datasets and additional tests. Moreover, these 
implementations are targeted at a single instance of a 
resource  and  are  not  designed  to  test  a  federated 
environment. Our goal is to address these challenges by 
developing  and  evaluating  a  framework  that  can 
support  systematic  testing  of  the  data  integrity  and 
correct operation of federated environments.  
Our  framework  has  two  main  elements:  a  test 
model,  representing  constraints  on  and  dependencies 
between  datasets  and  data  sources  in  the  federated 
environment,  and  a  family  of  testing  techniques  that 
leverage the model to test data integrity and accuracy 
of  the  environment.  The  test  model  is  a  set  of  rules 
derived from (1) data models of individual data sources 
and  constraints  expressed  in  the  data  models,  (2) 
relationships  among  different  data  models  and  data 
sources, (3) business processes (e.g., study protocols), 
(4) user-defined rules and constraints, and (5) rules and 
constraints  based  on  domain  knowledge.  The  testing 
techniques are driven by the test model and assess the 
federated environment by (1) identifying relevant test 
scenarios for the environment, (2) creating test cases 
that  realize  such  scenarios,  (3)  generating  (when 
needed)  suitably  tagged  synthetic  data  to  enable  the 
scenarios, and (4) executing the generated test cases. 
2.  Motivation and Objective   
Our effort is motivated mainly by translational research 
projects  supported  by  the  Atlanta  Clinical  and 
Translational  Science  Institute  (ACTSI),  a  multi-
institutional  partnership  funded  by  the  NIH  Clinical 
and Translational Science Awards program. A common 
theme among a wide range of studies undertaken by 
ACTSI  investigators  is  that  biomedical  data  are 
captured at multiple locations and stored in different 
systems  (e.g.,  multiple  i2b2  [5]  instances)  hosted  by 
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partnering institutions. It is worth noting that many of 
the  research  scenarios  supported  within  ACTSI  are 
common use cases in other clinical research efforts.  
  To  illustrate  the  issues  we  target,  we  consider  a 
specific example: the study of brain tumors conducted 
in  the  In  Silico  Brain  Tumor  Research  Center 
(ISBTRC)
1  through  in  silico  experiments  on  data 
collected  from  a  group  of  patients.  Datasets  for  this 
study  encompass  high-throughput  omics  data, 
radiology and pathology image data, clinical data, such 
as diagnosis and survival, and tissue data. The datasets 
are obtained from public databases (e.g., Rembrandt
2 
and The Cancer Genome Atlas
3), derived from primary 
datasets  (e.g.,  image  analysis  results),  and  collected 
from subjects at the collaborating institutions.  
In  the  course  of  the  study,  the  primary  datasets 
from public resources are downloaded to local clinical, 
imaging,  and  genomic  databases  for  further  analysis 
and  cyclically  updated  to  include  new  data.  These 
datasets  are  expected  to  have  gene  expression, 
microarray,  mRNA,  and  miRNA  data,  radiology  and 
high-power light microscopy image data, and clinical 
diagnosis and survival outcome for each patient. For 
subjects at the collaborating institutions, tissue samples 
are collected following the study protocol. Microscopy 
image data are obtained from the tissue samples; two 
modalities  of  microscopy  image  data  are  captured  at 
Emory (brightfield microscopy images by a pathology 
imaging  group  for  every  subject  and  quantum  dot 
immunohistochemistry  images  by  a  nanotechnology 
center for some subjects). Each subject’s de-identified 
clinical  information  is  maintained  in  a  clinical  data-
management  system.  Gene  expression  datasets  are 
stored in a molecular database, whereas imaging data 
are  managed  in  radiology  and  microscopy  imaging 
databases. The primary datasets are analyzed using a 
suite of analysis algorithms and by human experts (in 
the case of image data). The omics analysis results are 
stored  in  a  molecular  database,  whereas  the  image 
analysis  results  are  stored  in  image  markup  and 
annotation databases.  
The data gathering and management processes in 
this study are complex and error prone, as they involve 
multiple  points  of  data  acquisition/generation  and 
multiple data management systems. There are multiple 
sources of error. For example, in one case, an image 
was  accidentally  deleted,  leaving  analysis  results 
obtained from that image unlinked to any image data. 
Errors may also arise due to incorrect identifiers and 
foreign-key  relationships  across  different  data 
generation  points  and  systems.  Different  institutions 
and  systems  maintain  local  identifiers  (e.g.,  de-
                                                              
1 http://cci.emory.edu/cms/projects/ISBTRC.html 
2 http://caintegrator-info.nci.nih.gov/rembrandt/ 
3 http://cancergenome.nih.gov/ 
identified specimen, patient, image identifiers), which 
need to be mapped to appropriate global identifiers and 
stored so that related data products can be linked and 
queried correctly. This is an error prone process.  If a 
system  in  the  environment  does  not  support  such 
identifiers  correctly,  or  mapping  scripts  are 
implemented  incorrectly,  join  queries  involving  that 
system will return incorrect results. 
As we mentioned in the Introduction, updates to 
data may introduce hard-to-detect errors. An erroneous 
update to some of the clinical data in our study, for 
instance,  resulted  in  incorrect  diagnosis  values  that 
conflicted with the expected progression of the disease. 
This is an example of the kind of domain knowledge 
that a testing framework should incorporate and check.  
As a final example, a time consuming inspection 
of  the  datasets  from  the  public  repositories  revealed 
that some of the required data for some subjects were 
missing (e.g., image data). The TCGA study included a 
set  of  manual  annotations  generated  by  a  set  of 
neuropathologists;  this  process  depended  on  the 
availability of digitized glass slides. In an early in silico 
experiment, we sought to replicate the results generated 
by  the  neuropathologists  using  a  set  of  custom-
developed  computer  algorithms.  We  eventually 
discovered  that  not  all  images  for  slides  used  in  the 
manual annotations were available for download on the 
TCGA  website,  which  led  to  an  extremely  labor 
intensive process to track down additional slides. Our 
framework would be able to capture such a discrepancy 
early in the process, by checking for the presence of 
data  based  on  the  study  protocol  requirements,  and 
notify the users of the issue. 
 The goal of our testing framework is to be able to 
detect and report these types of errors using a suite of 
techniques that combine domain knowledge, modeling, 
and software testing methods. 
 
3.  Approach 
Figure 1 provides a depiction of our framework, which 
consists of a set of testing techniques and a test model 
that  are  tightly  integrated.  In  addition,  it  contains  a 
data-mining  element,  which  can  provide  support  for 
extracting rules from the federated environment. In this 
framework,  test  cases  are  run  both  offline,  before 
deployment, and online, to monitor whether changes to 
the  environment  violate  any  of  the  dependencies  or 
constraints encoded in the identified rules. 
3.1.  Test Model 
The test model is used to provide a specification of the 
expected  correct  state  and  function  of  a  federated 
environment.  It  describes  constraints,  dependencies, 
and relationships imposed on data and resources. Our 
approach  draws  from  the  principles  and  practices 
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implemented  in  frameworks  for  data  and  systems 
interoperability  [6].  The  key  components  of  these 
frameworks are system specifications (based on static, 
functional,  and  behavioral  semantics),  conformance 
statements, and conformance assertions. Conformance 
statements  are  derived  from  specifications,  and 
conformance  assertions  are  evaluated  against  the 
conformance  statements  to  assess  the  level  of 
interoperability between systems. The test model in our 
case  becomes  a  key  to  system  specifications  and 
statements expressed as a set of properties and rules in 
a semantic language (OWL and SWRL [7,8]). Testing 
techniques evaluate conformance assertions against the 
specifications and statements. We employ the notions 
of  information,  functional,  and  process  semantics  to 
create the test model for a given federated environment. 
 
3.1.1.  Information Semantics 
Information  semantics  represent  the  set  of  properties 
and  rules  that  can  be  derived  from  data  models  in 
individual databases and constraints associated with the 
data models. The first aspect of information semantics 
is the use of value domains and value sets to express 
permissible  and  non-permissible  values  for  data 
elements.  This  aspect  can  be  used  to  create  rules  to 
express data value constraints. For example, if a data 
attribute maintains values on a patient’s height, it may 
have  been  assigned  a  value  set  of  [1,8]  feet.  In  that 
case,  the  test  model  could  include  the  following 
corresponding  set  of  rules:  AttrX.domain=numerical; 
AttrX.unit=foot; AttrX.range =[1,8]. 
Another relevant aspect of information semantics 
is the description of relationships between data models 
within  and  across  databases.  In  our  framework,  this 
aspect results in rules that describe how data elements 
in different databases are related, whether they are used 
to store semantically equivalent data, and so on. For 
example, a rule stating that “Attribute X in Database A 
is the same as Attribute Y in Database B,” 
encoded  as 
haveSameValue(DB_A,AttrX,DB_B,AttrY), 
could  be  created  to  express  that  the  two 
attributes should have the same value.   
A  third  aspect  of  information 
semantics  is  the  incorporation  of  domain 
knowledge.  As  our  understanding  of 
biological systems and diseases progresses, 
certain  relationships,  hierarchies,  and 
axioms  are  deemed  as  domain  facts  and 
incorporated  into  ontologies  representing 
domain knowledge. The test model makes 
use of domain ontologies to express rules 
that  describe  constraints  and  relationships 
derived  from  the  domain  knowledge.  For 
instance,  a  domain  ontology  may  define 
that “Stage II always follows Stage I, and Stage I never 
follows Stage II for disease Z,”. The test model then 
contains  the  rule 
∀t1>t2⇒DiseaseZ.Stage[t1]<DiseaseZ.Stage[t2], 
where t1 and t2 indicate timestamps. 
3.1.2.  Functional Semantics 
Functional semantics describe the expected behavior of 
a system (e.g., error conditions, returns on successful 
invocation of the system) when it is interacted with. In 
our case, functional semantics are used to define rules 
on  the  behavior  of  the  system  for  (1)  data  loads, 
updates, and deletes, (2) successful query executions, 
and  (3)  error  conditions.  For  instance,  if  new  object 
identifiers should be generated, when new data objects 
are  loaded  to  a  system,  a  rule  expressing  which 
identifiers  should  or  should  not  be  generated  can  be 
defined as part of the test model. 
3.1.3.  Process Semantics 
Process  semantics  describe  business  processes  and 
relationships  between  databases  and  systems  that  are 
not part of information and functional semantics. For 
example, in the study described in Section 2, the study 
protocol  corresponds  to  the  business  processes.  The 
protocol describes which data should be obtained for 
each patient and how many instances of a given data 
type  should  be  gathered.  The  process  semantics  of 
acquiring microscopy imaging data can lead to a rule 
stating that “an image data item for the in silico brain 
tumor study must be of type InSilicoImageData, have 
two  bright-field  H&E  whole-slide  images,  and  have 
two quantum-dot images.” (For clarity, we show these 
rules in natural language.) Another rule may combine 
the image data with other data types for the brain tumor 
study:  “A  dataset  for  the  in-silico  brain  tumor  study 
must  contain  data  items  of  type  InSilicoImageData, 
patient survival data, sequence data, and mRNA data.” 
 
Figure 1: Intuitive view of the proposed framework. 
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This  set  of  rules  can  be  used  to  evaluate  if  the 
necessary  data  elements  have  been  collected  for  a 
subject  in  the  brain  tumor  study.  In  our  framework, 
process  semantics  is  also  employed  to  derive  user-
defined rules on dependencies and relationships among 
two  or  more  databases.  For  instance,  a  rule  can  be 
defined to specify that: “if there are image-annotation 
results in the image-annotations database, there must be 
a corresponding image in the image database.” 
We have identified these three components for test 
model creation based on our experience with several 
use  cases.  Our  main  goal  with  the  test  model  is  to 
provide  a  high-level  mechanism  for  users  and 
developers to represent constraints, dependencies, and 
relationships. Nevertheless, we are building the testing 
system such that application-specific test scripts can be 
executed for cases the test model is not sufficient. 
 We plan to examine automated mechanisms and 
data mining to create rules from data models, datasets, 
and domain knowledge. Some rules in the test model 
can automatically be derived from the data models. For 
example, schema constraints on associations could be 
used  to  describe  rules  on  such  associations.  In  data 
models  where  data  elements  are  semantically 
annotated,  and  associated  with  value  sets  for 
permissible or non-permissible values, rules could be 
created on such value sets to describe constraints on the 
data  elements.  Data  mining  may  also  be  applied  to 
identify  strong  correlations  among  the  data  that  can 
indicate the presence of latent rules. Such inferred rules 
may be used to identify anomalies in the data -- data 
mining was successfully used to this end in previous 
work (e.g., [11,12]).  
 
3.2.  Testing Techniques 
Our main goal is to assess the integrity and accuracy of 
the  environment’s  data  sources  and  datasets  with 
respect to the rules in the test model. In this section, we 
describe how our approach accomplishes this goal and 
illustrate its application on some of the examples from 
Section 3.1.  
3.2.1.  Test Generation and Execution 
Tests are typically defined according to a given set of 
requirements (e.g., coverage of some code elements). 
In our case, the key aspects to be tested are the data 
elements  and  the  rules  defined  over  them.  Thus,  the 
starting point for our approach is the test model. More 
precisely,  our  approach  analyzes  the  test  model  to 
identify  relevant  data  elements,  discover  the  rules 
involving  such  elements,  and  generate  testing 
requirements (and ultimately tests) based on such rules. 
The  specific  kind  of  tests  generated  depends  on  the 
type of rule being analyzed. Consider, for instance, the 
rules presented in Section 3.1.1. The analysis of rule 
haveSameValue(DB_A,AttrX,DB_B,AttrY) would result 
in  offline  tests  that  check  that  “for  corresponding 
elements a and b in Databases A and B, respectively, 
a.X and b.Y must have the same value.” (The specific 
number of tests generated would depend on the amount 
of resources available for testing.) The framework can 
instantiate  these  tests  and  run  them  on  the  databases 
automatically, so as to identify and report violation of 
this  rule.  Another  example  is  provided  by  rule 
∀t1>t2⇒DiseaseZ.Stage[t1]<DiseaseZ.Stage[t2].  In 
this case, the analysis of the rule would result in a set 
of online tests that would be implemented as runtime 
monitors  deployed  on  the  federated  datasets.  The 
monitors would be triggered by changes that affect the 
value  of  one  or  more  DiseaseZ.Stage  fields,  would 
check that the new value of the fields is greater than the 
old values, and report a problem if this is not the case. 
3.2.2.  Data Generation 
In  some  cases,  real  datasets  may  be  inadequate  and 
prevent some of the tests from being run. For example, 
a  test  that  checks  whether  n  types  of  data  collected 
from  m  different  databases  are  aggregated  correctly 
may need data of exactly the right types in the different 
databases involved, and this data may not be present. 
Moreover, for some more sophisticated tests, data with 
a specific distribution may be needed. Finally, in cases 
where  an  accurate  test  oracle  is  defined,  differential 
testing may be needed to assess the outcome of a test. 
When generating synthetic data sets, the data must 
typically have characteristics representative of real data 
and  cannot  be  simply  randomly  generated.  We  will 
leverage existing techniques for generating meaningful, 
valid synthetic data (e.g., [9,10]) and will extend them 
to support distributed data sources. Our framework will 
use information about relationships and dependencies 
among  database  schemas,  generate  synthetic  datasets 
according  to  this  information  and  on  the  generated 
tests,  and  populate  data  across  the  distributed 
databases.  As  an  example  of  this  scenario,  consider 
another  rule  from  Section  3.1: 
AttrX.domain=numerical; AttrX.unit=foot; AttrX.range 
=[1,8].  To  execute  a  test  that  targets  this  rule,  the 
framework  may  need  to  add  to  a  database  suitably 
tagged synthetic patients, whose AttrX’s value violates 
the domain, unit, or range constraints. 
4.  Current State of Testing Framework 
We are in the process of implementing a prototype of 
our  framework.  Presently,  we  are  building  a  brain 
tumor translational informatics test bed that contains a 
wide  range  of  real  data  from  the  brain  tumor  study 
described  in  Section  2.  The  datasets  come  from  the 
TCGA
3, Rembrandt
2, and NBIA
4 data repositories and 
                                                              
4 National Biomedical Imaging Archive http://imaging.nci.nih.gov 
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from Emory University, Thomas Jefferson University, 
and  Henry  Ford  Hospital  (three  of  the  collaborating 
institutions in ISBTRC
1). Table 1 lists the datasets and 
data  management  systems  for  the  test  bed.  The  data 
management  systems  will  be  deployed  on  a  set  of 
virtual machines for easier portability and distributed 
deployment.  The  test  bed  will  allow  us  to  create 
scenarios for various types of errors, such as incorrect 
mappings  from  local  identifiers  to  global  identifiers 
(i.e.,  foreign  key  relationships  –  the  molecular, 
imaging, and clinical data stored in different systems 
should  be  linked  through  subject  and/or  specimen 
identifiers),  missing  data  with  respect  to  the  study 
protocol  (e.g.,  missing  whole  slide  images  for  some 
patients), and updates to invariant data elements (e.g., 
disease diagnoses, dates of death). In parallel, we are 
incrementally building our test model by defining rules 
for properties, constraints, and relationships among the 
databases in the study. We have defined several rules 
using OWL and SWRL for immutable data elements, 
the study protocol, and foreign key relationships. Our 
test bed will eventually provide the end users with (1) a 
set of test cases that are automatically generated using 
the test model, (2) a method to automatically execute 
the test cases, and (3) a report of the test outcome for 
users.   
5.  Conclusion 
Testing is often overlooked in federated settings and 
accomplished  via  one-off  implementations.  An 
integrated middleware framework can provide a cost-
effective solution to this problem. Such a framework 
should enable researchers and database administrators 
to:  (1)  specify  a  description  of  the  correct  state  and 
function  of  the  system  as  a  set  of  rules  expressing 
dependencies,  relationships,  and  constraints  on  data 
sources  and  datasets;  and  (2)  create,  based  on  the 
identified  set  of  rules,  relevant  test  scenarios  for  the 
federated  environment,  test  cases  that  realize  such 
scenarios, and suitably tagged synthetic data, when the 
existing data are not sufficient. 
Type of Dataset  Data Management System 
Neuroimaging Data 
Radiology images in DICOM 
format, imaging metadata 
Virtual PACS
5, xNAT
6 
Manual annotations provided by 
neuroradiologists 
AIME
5,7  
Molecular Data 
mRNA, miRNA, methylation 
data, copy number, sequence data 
in-house developed database 
with file system for data files 
                                                              
5 https://cabig.nci.nih.gov/tools/IMAG_Middleware 
6 eXtensible Neuroimaging Archive Toolkit, http://xnat.org 
7 Annotation and Image Markup, https://cabig.nci.nih.gov/tools/AIM 
Clinical Data 
Clinical data (including days to 
death, diagnosis, year of initial 
pathologic diagnosis), specimen 
(e.g., sample type), etc., data 
i2b2
8, in-house developed 
database 
Pathology Data 
Whole slide microscopy images as 
20x and 40x magnification, image 
metadata 
caMicroscope
9 
Computer- and human-generated 
annotations of pathology images 
PAIS
10 
Table 1: Datasets and data management systems in the 
test bed. 
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